Year, Beats Consensus by 15% Adjusted EBITDA of $17.7 Million, Beats Consensus by 15% Raises Full-Year 2026 Revenue Growth ...
EndoQuest Robotics, Inc., developer of flexible robotic technology for endoluminal procedures, today announced the successful ...